Home › Funds › Sageworth Trust Co › ABBV
Sageworth Trust Co position in ABBV
ABBVIE INC · Health Care
Sageworth Trust Co reported holding 18,347 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$4.8M, representing 0.21% of its reported portfolio and ranking #26 among its reported holdings. Sageworth Trust Co has disclosed ABBV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sageworth Trust Co's ABBV position evolved
Sageworth Trust Co first disclosed a stake in ABBV in Q2 2025 at 21,989 shares (US$4.1M). The position peaked in Q3 2025 at 29,161 shares, worth US$6.8M. Across 6 filings, Sageworth Trust Co increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 18,347 shares valued at US$4.8M. Notable position changes include a 33% increase in Q3 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 21.99K | $4.08M | New |
| Q3 2025 | 29.16K | $6.75M | Add |
| Q4 2025 | 22.71K | $5.19M | Reduce |
| Q1 2026 | 23.01K | $5.00M | Add |
| Q2 2026 | 18.31K | $4.61M | Reduce |
| Q3 2026 | 18.35K | $4.80M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABBV and 13F data
ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 115.68M sh · $30.26B · Q3 2026
- STATE STREET CORP 82.82M sh · $21.66B · Q3 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 49.00M sh · $12.82B · Q3 2026
- Geode Capital Management 47.50M sh · $12.40B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 31.12M sh · $8.14B · Q3 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
- Franklin Resources 19.70M sh · $5.81B · Q3 2026
More on Sageworth Trust Co
FAQ
How long has Sageworth Trust Co held ABBV?
Sageworth Trust Co has disclosed ABBV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Sageworth Trust Co's current position in ABBV?
As of Q3 2026, Sageworth Trust Co holds 18.35K shares of ABBV (ABBVIE INC), valued at $4.80M, representing 0.21% of its reported portfolio and ranking #26.
Has Sageworth Trust Co been buying or selling ABBV?
In the latest 13F filing (Q3 2026), Sageworth Trust Co held unchanged its position in ABBV. The position peaked in Q3 2025 at 29.16K shares.
Which other funds hold ABBV?
Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.